Suchergebnisse - "Mandato, Elisa"

PubPharm (10)

1

CK2β Regulates Hematopoietic Stem Cell Biology and Erythropoiesis

enthalten in: HemaSphere | 2023

von Quotti Tubi, L. | Canovas Nunes, S. | Mandato, E. | +20

2

TP63 fusions drive multicomplex enhancer rewiring, lymphomagenesis, and EZH2 dependence

enthalten in: Science translational medicine | 2023

von Wu, G. | Yoshida, N. | Liu, J. | +36

3

CK2β-regulated signaling controls B cell differentiation and function

enthalten in: Frontiers in immunology | 2022

von Quotti Tubi, L. | Mandato, E. | Canovas Nunes, S. | +22

4

A peripheral immune signature of responsiveness to PD-1 blockade in patients with classical Hodgkin lymphoma

enthalten in: Nature medicine | 2020

von Cader, F. | Hu, X. | Goh, W. | +15

5

Targeted inhibition of PI3Kα/δ is synergistic with BCL-2 blockade in genetically defined subtypes of DLBCL

enthalten in: Blood | 2019

von Bojarczuk, K. | Wienand, K. | Ryan, J. | +8

6

The small GTPase RhoU lays downstream of JAK/STAT signaling and mediates cell migration in multiple myeloma

enthalten in: Blood cancer journal | 2018

von Canovas Nunes, S. | Manzoni, M. | Pizzi, M. | +12

7

CX-4945, a Selective Inhibitor of Casein Kinase 2, Synergizes with B Cell Receptor Signaling Inhibitors in Inducing Diffuse Large B Cell Lymphoma Cell Death

enthalten in: Current cancer drug targets | 2018

von Mandato, E. | Nunes, S. | Zaffino, F. | +7

8

CX-4945, a Selective Inhibitor of Casein Kinase 2, Synergizes with B Cell Receptor Signaling Inhibitors in Inducing Diffuse Large B Cell Lymphoma Cell Death

enthalten in: Current cancer drug targets | 2018

von Mandato, E. | Nunes, S. | Zaffino, F. | +7

9

Protein kinase CK2 is widely expressed in follicular, Burkitt and diffuse large B-cell lymphomas and propels malignant B-cell growth

enthalten in: Oncotarget | 2015

von Pizzi, M. | Piazza, F. | Agostinelli, C. | +7

10

Protein kinase CK2 inhibition down modulates the NF-κB and STAT3 survival pathways, enhances the cellular proteotoxic stress and synergistically boosts the cytotoxic effect of bortezomib on multiple myeloma and mantle cell lymphoma cells

enthalten in: PloS one | 2013

von Manni, S. | Brancalion, A. | Mandato, E. | +14

1
[1]